Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice

被引:16
|
作者
Narasimhulu, Chandrakala Aluganti [1 ]
Mitra, Connie [1 ]
Bhardwaj, Deepshikha [1 ]
Burge, Kathryn Young [1 ]
Parthasarathy, Sampath [1 ]
机构
[1] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA
关键词
Atherosclerosis; blood-brain barrier; neurological markers; PON1; APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; MOUSE MODEL; ATHEROSCLEROSIS; POLYMORPHISMS; PATHOGENESIS; ASSOCIATION; MACROPHAGES; PLAQUE; BRAIN;
D O I
10.3233/JAD-180883
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) is a neurodegenerative disorder associated with aging. Cardiovascular risk factors like hypertension and atherosclerosis increase the risk for AD. Polymorphic alleles of apolipoprotein E (ApoE) are one of the main genetic determinants of AD. Objective: Mice, double-knockout (DKO) for ApoE (major cholesterol carrier in brain) and PON1 (paroxonase1, reduces oxidative stress), showed severe age-dependent atherosclerosis of the arteries carrying blood to the brain even on normal diet. This prompted us to investigate the possibility of an AD pathology resulting from the deficiency of ApoE and the induction of oxidative stress. Methods: Atherosclerotic lesions were quantified by ImageJ. The brain hippocampus of young and old ApoE-PON1 DKO mice and control mice were harvested. RT-PCR analysis was performed for mRNA levels of AD specific markers. Blood levels of S100 calcium-binding protein B (S100B) protein were measured by ELISA. H&E as well as immunostaining was performed to detect amyloid-beta (A beta) plaques and neurofibrillary tangles (NFTs) in brain tissues. Evans blue dye was used to evaluate the vascular permeability and blood-brain barrier (BBB) dysfunction. Results: Results showed that the older DKO mice had severe carotid atherosclerosis, increased mRNA levels of AD markers in brain tissue, and elevated levels of serum S100B protein. Immunological staining confirmed the characteristics of AD. Ex-vivo imaging showed higher levels of Evans blue dye in the ApoE-PON1 DKO mice brain tissues, pointing toward impaired vasculature. Conclusion: Aged ApoE-PON1 DKO mice displaying AD specific markers along with A beta plaques, NFTs, and disrupted BBB suggests the animals are suffering from AD.
引用
收藏
页码:1353 / 1365
页数:13
相关论文
共 50 条
  • [21] PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles
    Trentini, Alessandro
    Rosta, Valentina
    Riccetti, Raffaella
    Mola, Gianmarco
    Galletti, Riccardo
    Pinotti, Marco
    Senia, Vincenza
    Zuliani, Giovanni
    Cervellati, Carlo
    ANTIOXIDANTS, 2024, 13 (10)
  • [22] Cerebrospinal fluid Alzheimer's disease markers in adult type 1 diabetes patients: associations with microangiopathy and APOE ε4
    Schoonenboom, N. S. M.
    van Duinkerken, E.
    IJzerman, R. G.
    Blankenstein, M. A.
    van Golen, L. W.
    Klein, M.
    Snoek, F. J.
    Scheltens, P.
    Diamant, M.
    DIABETOLOGIA, 2011, 54 : S516 - S517
  • [23] S-Nitrosylation of ApoE in Alzheimer's Disease
    Abrams, Alexander J.
    Farooq, Amjad
    Wang, Gaofeng
    BIOCHEMISTRY, 2011, 50 (17) : 3405 - 3407
  • [24] APOE and metabolic dysfunction in Alzheimer's disease
    Johnson, Lance A.
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 131 - 151
  • [25] The ApoE gene of Alzheimer's disease (AD)
    P. K. Krishnan Namboori
    K. V. Vineeth
    V. Rohith
    Ibnul Hassan
    Lekshmi Sekhar
    Akhila Sekhar
    M. Nidheesh
    Functional & Integrative Genomics, 2011, 11 : 519 - 522
  • [26] APOE, Alzheimer's Disease, and Hispanic Populations
    Blue, Elizabeth E.
    Horimoto, Andrea R. V. R.
    Wijsman, Ellen M.
    Thornton, Timothy A.
    GENETIC EPIDEMIOLOGY, 2018, 42 (07) : 690 - 690
  • [27] EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease
    Tai, Leon M.
    Balu, Deebika
    Avila-Munoz, Evangelina
    Abdullah, Laila
    Thomas, Riya
    Collins, Nicole
    Valencia-Olvera, Ana Carolina
    LaDu, Mary Jo
    JOURNAL OF LIPID RESEARCH, 2017, 58 (09) : 1733 - 1755
  • [28] ApoE and regenerative mechanisms in Alzheimer's disease
    Teter, B
    Chu, T
    Lim, G
    Morihara, T
    Cole, G
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S403 - S403
  • [29] APOE and cholesterol homeostasis in Alzheimer's disease
    Leduc, Valerie
    Jasmin-Belanger, Stephanie
    Poirier, Judes
    TRENDS IN MOLECULAR MEDICINE, 2010, 16 (10) : 469 - 477
  • [30] The evolution of Alzheimer's disease and ApoE isoforms
    Bons, N
    NEUROBIOLOGY OF AGING, 1999, 20 (04) : 455 - 456